arrow
K

Kristin Goddard

Tyson School of Medicine
H指数:38
被引数:5,503

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Attitudes and beliefs regarding COVID-19 and COVID-19 Omicron booster vaccine among adults in the vaccine safety datalink, 2022-2023

关于COVID-19及COVID-19 Omicron加强疫苗在疫苗安全数据链中成年人的态度和信念,2022-2023

2025-04-030
OA
Attitudes of California school personnel on potential COVID-19 vaccine mandates and state law SB277 to remove nonmedical vaccine exemptions

加利福尼亚州学校人员对潜在的COVID-19疫苗强制接种令及州法律SB277(关于取消非医疗疫苗接种豁免)的态度

VACCINE
IF3.5
2025-04-010
PRE
Influenza Vaccine Effectiveness Against Influenza A-Associated Emergency Department, Urgent Care, and Hospitalization Encounters Among US Adults, 2022-2023

流感疫苗对美国成年人甲型流感相关急诊科,紧急护理和住院治疗的有效性,2022-2023

2023-12-027
OA
Vaccine Effectiveness Against Pediatric Influenza-A-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2022-2023 Season: VISION Network
2023-11-167
OA
Clinical Epidemiology and Risk Factors for Critical Outcomes Among Vaccinated and Unvaccinated Adults Hospitalized With Coronavirus Disease 2019-VISION Network, 10 States, June 2021-March 2023
2023-08-2613
OA
Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19-Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions-VISION Network, September 2022-April 2023
2023-07-016
PRE
Effectiveness of BNT162b2 COVID-19 Vaccination in Children and Adolescents
2023-04-078
PRE
Vaccine Effectiveness Against Influenza-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2021-2022 Season, VISION Network
2023-01-2311
OA
Protection of Two and Three mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized With COVID-19-VISION Network, August 2021 to March 2022
2022-11-235
OA
Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control study

来自VISION network的美国成年人对中度和重度新型冠状病毒肺炎的疫苗有效性减弱: 测试阴性,病例对照研究

2022-10-03111
OAAI
Safety of COVID-19 Vaccination in United States Children Ages 5 to 11 Years
2022-07-1440
OA